NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding
In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR
Fisher and Redmond Subject Of Misconduct Investigation; ORI
Herberman Outlines NSABP restructuring In Plan To NCI
DCT Advisors Approve Increased Spending On Trials Monitoring
Possible Breach of Patient Confidentially By Calif. Physician; NCI
Trending Stories
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation - A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Group chairs propose funding strategy to jump-start correlative studies
- Karen Knudsen to leave ACS
- 2024 Lasker Awards honor discoveries in antitumor immunity, GLP-1-based drugs, and research, advocacy in HIV/AIDS